The novel therapy of this peptide represents a major breakthrough in the management of type 2 diabetes. Different to existing therapies, tirzepatide targets two pathways – the GLP-1 hormone and GIP – leading to https://tirzepatidepeptide146188.pages10.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-77465010